GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chempartner Pharmatech Co Ltd (SZSE:300149) » Definitions » Cash-to-Debt

Chempartner Pharmatech Co (SZSE:300149) Cash-to-Debt : 0.67 (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chempartner Pharmatech Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Chempartner Pharmatech Co's cash to debt ratio for the quarter that ended in Sep. 2024 was 0.67.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Chempartner Pharmatech Co couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Chempartner Pharmatech Co's Cash-to-Debt or its related term are showing as below:

SZSE:300149' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04   Med: 0.55   Max: No Debt
Current: 0.67

During the past 13 years, Chempartner Pharmatech Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.04. And the median was 0.55.

SZSE:300149's Cash-to-Debt is ranked worse than
80.36% of 1487 companies
in the Biotechnology industry
Industry Median: 6.38 vs SZSE:300149: 0.67

Chempartner Pharmatech Co Cash-to-Debt Historical Data

The historical data trend for Chempartner Pharmatech Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Chempartner Pharmatech Co Cash-to-Debt Chart

Chempartner Pharmatech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.25 0.10 0.79 0.55

Chempartner Pharmatech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.55 0.54 0.55 0.67

Competitive Comparison of Chempartner Pharmatech Co's Cash-to-Debt

For the Biotechnology subindustry, Chempartner Pharmatech Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chempartner Pharmatech Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chempartner Pharmatech Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Chempartner Pharmatech Co's Cash-to-Debt falls into.



Chempartner Pharmatech Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Chempartner Pharmatech Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Chempartner Pharmatech Co's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chempartner Pharmatech Co  (SZSE:300149) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Chempartner Pharmatech Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Chempartner Pharmatech Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Chempartner Pharmatech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 268 Dongfeng Middle Road, 28th Floor, Exchange Square, Yuexiu District, Guangzhou City, Guangdong, CHN, 529081
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
Executives
Qi Jia Hui Supervisors
Yang Xin Qiu Executives
Ceng Xian Jing Director
Xie Yong Kui Director
Zhou Xin Ping Director
Wang Cong Wei Director

Chempartner Pharmatech Co Headlines

No Headlines